The World Health Organization (WHO) has published its first-ever report addressing the lack of medicines and diagnostic tools for invasive fungal diseases.
Rare Diseases International, whose community engages with the World Health Organization, examines rare diseases and health equity, emphasising shifting the paradigm through global action.
Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, the leading lung charity, discusses the socioeconomic costs of lung conditions and the need for great lung health research.
Examining the macrophage populations in the synovium of patients with Rheumatoid Arthritis (RA) hopes to help uncover their role in RA pathogenesis better
Inflammatory skin diseases like psoriasis involve interactions between skin cells (keratinocytes) and immune cells, which leads to chronic inflammation, disfiguring skin lesions, and systemic effects.
In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.
A new project is expected to help us understand diseases such as cancer and dementia. A major partnership involving Oxford Nanopore Technologies, UK Biobank, NHS England, Genomics England, and the UK government has made this possible.
The NHS in England has introduced a new therapy that hopes to transform the lives of hundreds of adults living with X-linked Hypophosphatemia (XLH), this rare genetic disorder causes severe bone, dental, and skeletal issues.
Dementia is the leading cause of death in the UK, having a huge impact on people living with the condition, their families and the health systems supporting them. We hear from Dementia UK’s Andrew Pike, Head of Policy, Campaigns and Public Affairs, about how the UK Government can help to alleviate these pressures, most notably through aiding specialist nursing support.
Sepsis causes 350,000 adult deaths annually in the US alone. Sepsis Alliance focuses on raising awareness, improving education, and advocating for life-saving policies. Senior Clinical Content Advisor Marijke Vroomen Durning discusses the risk factors and best prevention methods to help in avoiding sepsis.
Despite the significant disease burden, Myalgic encephalomyelitis (ME), previously known as chronic fatigue syndrome (CFS), lacks effective diagnostics and therapeutics. Emily Taylor, President and CEO of Solve M.E., explains why dedicated research for Infection-Associated Chronic Conditions and Illnesses (IACCIs) such as ME/CFS is vitally needed.
A study that was reported on in the Lancet Neurology showed that over 3 billion people worldwide are living with neurological conditions, making these disorders the leading cause of illness and disability globally.
